Pharmaceutical Sector Will Benefit From Reform

BMI View: France is one of the leading drug manufacturers in the world and is an important research and development (R&D) site for major multinationals. However, the global life sciences industry is becoming more and more competitive, with governments increasingly pushing growth in the sector through research and innovation. BMI therefore believes the government must work to maintain the country's position as an attractive R&D and manufacturing base. France scores well in our Q111 Pharmaceuticals and Healthcare Business Environment Ratings - it is ranked tenth globally (out of the 83 markets in BMI's coverage universe) and fourth in our Western

To read the full article, please choose one of the following options: